ARQL

ArQule, Inc. News Headlines

$1.35
*  
0.04
2.88%
Get ARQL Alerts
*Delayed - data as of Jul. 28, 2014  -  Find a broker to begin trading ARQL now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

George Zavoico: Biotech Stocks That Deserve A Closer Look
3/8/2013 3:15:00 AM - Seeking Alpha

5 Speculative Biotech Stocks With Catalysts Pending
2/25/2013 9:50:00 AM - Seeking Alpha

3 Biopharma Catalyst Trades To Consider For Today
2/6/2013 12:23:37 PM - Trefis

Synergy Starts SP-333 Phase I Study - Analyst Blog
1/29/2013 5:50:01 PM - Zacks.com

Latest Tivantinib Failure Hits ArQule Despite Its Irrelevance
1/15/2013 5:40:00 AM - Seeking Alpha

Setback for ArQule, Shares Fall - Analyst Blog
1/14/2013 2:20:01 PM - Zacks.com

Pre-Market Most Active for Jan 11, 2013 : MT, BAC, WFC, NOK, DNDN, BBY, SAP, FB, RIMM, SIRI, AAPL, ARQL
1/11/2013 9:39:54 AM - NASDAQ.com News

Thursday's Small Cap Biotech Catalyst Watch List
1/3/2013 8:30:00 AM - Seeking Alpha

Biotech Portfolio Update: 2012 Summary And 2013 Outlook
12/24/2012 7:24:00 AM - Seeking Alpha

ArQule: A Strong Speculation BioPharma Poised For A Quick Move Up On Near Term Catalyst
12/19/2012 8:00:00 AM - Seeking Alpha

Strong Small Cap Biopharma Catalyst Trades And Investments For Consideration
12/18/2012 7:55:00 AM - Seeking Alpha

ArQule: An Inexpensive And Well-Financed Oncology Opportunity
12/13/2012 1:57:00 PM - Seeking Alpha

Neuralstem Is Speculative, But Its Work In Stem Cell Therapy Can't Be Ignored
11/6/2012 1:15:04 AM - SeekingAlpha

ArQule's Tivantinib Failure And Exelixis' Cabozantinib PDUFA: Is There A Correlation?
10/12/2012 9:10:00 AM - Seeking Alpha

Weekend Recap: Biotech Madness
10/6/2012 4:13:00 PM - Seeking Alpha

Zacks #1 Rank Additions for Wednesday - Tale of the Tape
10/3/2012 8:49:47 AM - Zacks.com

As ArQule Investors Panic, Watch Exelixis Too
10/3/2012 8:19:00 AM - Seeking Alpha

7 Innovative Biotechs That Could Soar By Year-End: George Zavoico
9/13/2012 4:00:00 PM - Seeking Alpha

Zacks #1 Rank Additions for Tuesday - Tale of the Tape
8/7/2012 9:14:01 AM - Zacks.com

Pre-Market Earnings Report for August 2, 2012 : APA, AEE, ANSS, ARIA, APO, ALE, AB, ABMD, AYR, AVD, ARQL, AGEN
8/1/2012 4:08:40 PM - NASDAQ.com News

Zacks #1 Rank Additions for Tuesday - Tale of the Tape
5/1/2012 9:14:01 AM - Zacks.com

Zacks #1 Rank Additions for Monday - Tale of the Tape
4/2/2012 9:14:01 AM - Zacks.com

Should Seattle Genetics Start Thinking More Like A Pharma Company?
3/14/2012 5:42:00 PM - Seeking Alpha

Arqule's Strategy Continues To Generate Value
1/23/2012 10:05:00 AM - Seeking Alpha

Company News for January 18, 2012 - Corporate Summary
1/18/2012 10:00:01 AM - Zacks.com